PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 115 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $11,000 | -88.3% | 139 | -88.8% | 0.00% | -100.0% |
| Q3 2015 | $94,000 | -7.8% | 1,243 | +42.2% | 0.00% | 0.0% |
| Q2 2015 | $102,000 | -51.7% | 874 | -2.1% | 0.00% | -50.0% |
| Q1 2015 | $211,000 | +348.9% | 893 | +263.0% | 0.00% | – |
| Q4 2014 | $47,000 | -24.2% | 246 | -5.4% | 0.00% | -100.0% |
| Q3 2014 | $62,000 | +6.9% | 260 | -70.5% | 0.00% | 0.0% |
| Q2 2014 | $58,000 | -43.1% | 882 | -10.4% | 0.00% | 0.0% |
| Q1 2014 | $102,000 | +29.1% | 984 | +28.3% | 0.00% | 0.0% |
| Q4 2013 | $79,000 | +92.7% | 767 | +0.8% | 0.00% | – |
| Q3 2013 | $41,000 | -80.9% | 761 | -84.3% | 0.00% | -100.0% |
| Q2 2013 | $215,000 | – | 4,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |